Health Care Declines on Trump Administration Concerns -- Health Care Roundup
Health-care companies fell amid concerns about regulation from the Trump administration. A retreat for UnitedHealth Group continued after President-elect Donald Trump vowed to root "middle men" out of ...
Novo’s New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way.
The end of Novo Nordisk’s supply problems could bring new headaches for the rest of the pharmaceutical industry, which now ...
Why the investor craze for Ozempic and rival weight-loss drugs may resume next year
Investors' focus could, however, shift back onto the possible market impacts of GLP-1 agonists in 2025, particularly as a result of a major expansion of current supplies after Novo Nordisk was given a ...
Weight-loss drugs draw Americans back to the doctor
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...
Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030
Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason. Patients ...
News Highlights: Top Company News of the Day - Monday at 3 AM ET
MSNBC and CNN Fight to Dig Out of a Postelection Ratings Hole Ratings for the No. 2 and No. 3 cable news networks have plummeted since Donald Trump's victory, while Fox News remains the leader. ABC ...